Gastroenterology news & research | Hospital Healthcare Europe

This website is intended for healthcare professionals only.

Gastroenterology

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

New statement supports switching to biosimilar from reference product in IBD

New statement supports switching to biosimilar from reference product in IBD

Results from NOR-SWITCH study support switch from Remicade® to Remsima®

Results from NOR-SWITCH study support switch from Remicade® to Remsima®

Janssen receives CHMP positive opinion for Stelara® for moderately to severely active Crohn’s disease

Janssen receives CHMP positive opinion for Stelara® for moderately to severely active Crohn’s disease

PENTAX Medical introduces new high definition video processor for gastrointestinal endoscopic imaging

PENTAX Medical introduces new high definition video processor for gastrointestinal endoscopic imaging

Merck partners with Array BioPharma and Pierre Fabre to initiate BRAF-mutant CRC trial

Merck partners with Array BioPharma and Pierre Fabre to initiate BRAF-mutant CRC trial

New faecal bank offers unusual cure

New faecal bank offers unusual cure

Almost half of patients with UC using conventional therapies are dissatisfied with their treatments

Almost half of patients with UC using conventional therapies are dissatisfied with their treatments

Treatment of peritoneal surface malignancies

International consensus report highlights need for improved management of CDI in IBD patients

International consensus report highlights need for improved management of CDI in IBD patients

Data presented at ECCO supports switching from reference to biosimilar infliximab

Data presented at ECCO supports switching from reference to biosimilar infliximab

First results from the GO-COLITIS UK study

First results from the GO-COLITIS UK study

Allergan completes transfer of European MA for Ironwood’s Constella® from Almirall S.A

Allergan completes transfer of European MA for Ironwood’s Constella® from Almirall S.A

Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis

Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis

ProStrakan and AstraZeneca enter into agreement for rights to Moventig® in Europe

ProStrakan and AstraZeneca enter into agreement for rights to Moventig® in Europe

Campaign to reduce delay in diagnosis for people with axial spondyloarthritis

Campaign to reduce delay in diagnosis for people with axial spondyloarthritis

Data shows effectiveness of biosimilar infliximab in patients with inflammatory bowel diseases

Data shows effectiveness of biosimilar infliximab in patients with inflammatory bowel diseases

x